T-MSIS provider-level spending data, Jan 2018 – Dec 2024
Injection, nivolumab
Total Paid
$218.8M
$218,833,808
Beneficiaries
32K
32,329
Avg $/Claim
$3,733
Utilization
1.8 claims/bene
86 providers
Each dot is a state. X = average cost per claim. Y = total spending.
Drag to zoom into a region
| # | State | Total Paid▼ | Avg $/Claim | Claims | Beneficiaries | Providers |
|---|---|---|---|---|---|---|
| 1 | CA | $61.9M | $3,158 | 19,592 | 9,018 | 20 |
| 2 | PR | $32.1M | $7,476 | 4,294 | 2,635 | 4 |
| 3 | NY | $17.9M | $6,439 | 2,787 | 1,946 | 6 |
| 4 | MI | $17.8M | $4,843 | 3,685 | 2,387 | 5 |
| 5 | KY | $16.0M | $6,394 | 2,504 | 1,507 | 4 |
| 6 | OH | $14.4M | $6,951 | 2,070 | 982 | 7 |
| 7 | CT | $13.4M | $2,996 | 4,473 | 2,480 | 3 |
| 8 | MA | $12.1M | $3,567 | 3,397 | 2,242 | 4 |
| 9 | NJ | $7.5M | $5,826 | 1,285 | 747 | 3 |
| 10 | WA | $4.5M | $1,789 | 2,511 | 1,825 | 2 |
| 11 | AZ | $4.2M | $3,737 | 1,123 | 650 | 3 |
| 12 | MS | $3.8M | $1,912 | 1,974 | 706 | 8 |
| 13 | VA | $3.1M | $3,127 | 999 | 529 | 4 |
| 14 | ME | $3.1M | $3,575 | 868 | 525 | 2 |
| 15 | PA | $2.4M | $1,330 | 1,807 | 1,156 | 6 |
| 16 | FL | $1.4M | $399 | 3,613 | 2,063 | 5 |
| 17 | NM | $992K | $7,515 | 132 | 102 | 1 |
| 18 | WI | $857K | $704 | 1,216 | 660 | 3 |
| 19 | RI | $782K | $5,359 | 146 | 72 | 1 |
| 20 | WV | $314K | $5,715 | 55 | 36 | 1 |
| 21 | AR | $96K | $2,351 | 41 | 24 | 1 |
| 22 | IL | $63K | $4,215 | 15 | 12 | 1 |
| 23 | TX | $17K | $870 | 20 | 12 | 1 |
| 24 | SC | $0 | $0 | 21 | 13 | 1 |